Companies › CLNN
Clene Inc (CLNN)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001822791 · EDGAR filings · Updated 2026-06-15
Clene Inc (CLNN) has reported institutional ownership of 18.6%, with 29 institutional managers holding positions valued at $10.8M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Latest updates
- 2026-06-15 — Insider transaction reported (Form 4)
- 2026-06-15 — Insider transaction reported (Form 4)
- 2026-06-15 — Insider transaction reported (Form 4)
- 2026-06-05 — Employee-plan registration (S-8) filed
- 2026-05-22 — SD filed
- 2026-05-22 — Current report (8-K) filed
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, Clene Inc has 29 institutional holders and institutional ownership of 18.6%.
Insider activity
Insiders reported 59 transactions (1 buys, 55 sells) across 4 reporting insiders, with a net reported value of −$3.55M.
Data flags from SEC filings
Related companies
FITLIFE BRANDS INC (FTLF) · Werewolf Therapeutics Inc (HOWL) · ENVOY MEDICAL INC (COCH) · Aytu BioPharma Inc (AYTU) · ORGANIGRAM GLOBAL INC (OGI) · ANNOVIS BIO INC (ANVS)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-15.